Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis

Mark A Rodrigues, David Seiffge, Neshika Samarasekera, Tom J Moullaali, Joanna M Wardlaw, Stefanie Schreiber, Tyler P Behymer, Vivek Khandwala, Robert J Stanton, Vaibhav Vagal, Daniel Woo, Marialuisa Zedde, Rosario Pascarella, Andreas Charidimou, Andrew Warren, Steven M Greenberg, Sebastian Eppinger, Thomas Gattringer, Barbara Casolla, Charlotte Cordonnier, Costanza Rossi
{"title":"Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis","authors":"Mark A Rodrigues, David Seiffge, Neshika Samarasekera, Tom J Moullaali, Joanna M Wardlaw, Stefanie Schreiber, Tyler P Behymer, Vivek Khandwala, Robert J Stanton, Vaibhav Vagal, Daniel Woo, Marialuisa Zedde, Rosario Pascarella, Andreas Charidimou, Andrew Warren, Steven M Greenberg, Sebastian Eppinger, Thomas Gattringer, Barbara Casolla, Charlotte Cordonnier, Costanza Rossi","doi":"10.1016/s1474-4422(25)00285-6","DOIUrl":null,"url":null,"abstract":"<h3>Background</h3>Patients with lobar intracerebral haemorrhage and MRI biomarkers of cerebral amyloid angiopathy have a greater risk of recurrent intracerebral haemorrhage than patients without these biomarkers. However, access to MRI is limited. We aimed to determine whether the Edinburgh CT-only and CT-<em>APOE</em> diagnostic criteria for cerebral amyloid angiopathy-related lobar intracerebral haemorrhage are associated with recurrent intracerebral haemorrhage.<h3>Methods</h3>We did a meta-analysis of individual patient data from cohort studies identified at the 2018 International cerebral amyloid angiopathy conference in Lille, France, assessing patients with lobar intracerebral haemorrhage with available diagnostic CT imaging that had been, or could be, rated for the Edinburgh cerebral amyloid angiopathy criteria imaging features, and with follow-up data for recurrent intracerebral haemorrhage and death. Eligible patients were aged 16 years or older with first or recurrent spontaneous lobar intracerebral haemorrhage diagnosed by non-contrast brain CT, with no evidence of an underlying cause other than cerebral small vessel disease. Collaborators provided individual patient-level data. The primary outcome was first recurrent intracerebral haemorrhage occurring at least 30 days after the index event, analysed using primary two-stage (cohort-level) and secondary one-stage (pooled) meta-analyses with multivariable regression models with a competing risk of death, adjusted for age, sex, and CT small vessel disease score. Pooled analyses were adjusted for previous intracerebral haemorrhage, dementia, hypertension, and cohort clustering. All analyses were done in R Project for Statistical Computing (version 4.5.0).<h3>Findings</h3>We included eight cohorts from Austria, France, Germany, Italy, the UK, and the USA, with 1705 eligible patients for the CT-only criteria. In the primary two-stage meta-analysis of the CT-only criteria (562 patients from three European cohorts, median age 76 years [IQR 68–82], 282 [50%] female and 280 [50%] male), 69 patients had a recurrent intracerebral haemorrhage over 1381 person-years’ follow-up. The proportion with recurrent intracerebral haemorrhage during 5-year follow-up in the intermediate-risk and high-risk CT-only cerebral amyloid angiopathy criteria group was 48 (16%) of 307 patients compared with 21 (8%) of 255 patients in the low-risk group (adjusted sub-distribution hazard ratio [HR] 1·79, 95% CI 1·05–3·05, p=0·032). In the one-stage meta-analysis of the CT-only criteria (1620 patients with lobar intracerebral haemorrhage from eight cohorts, median age 73 years [IQR 62–80], 763 [47%] female and 857 [53%] male), 171 patients had a recurrent intracerebral haemorrhage over 3208 person-years’ follow-up. Cumulative 5-year incidence of recurrent intracerebral haemorrhage in the low-risk CT-only cerebral amyloid angiopathy criteria group was 45 (12%) of 727 patients compared with 54 (16%) of 513 patients in the intermediate-risk group (adjusted sub-distribution HR 1·68, 95% CI 1·21–2·32; p=0·0018), and 72 (26%) of 380 patients in the high-risk group (adjusted sub-distribution HR 2·97, 1·50–5·89, p=0·0018). We included six cohorts with 1021 eligible patients for the CT-<em>APOE</em> criteria; 15 patients with missing baseline data were excluded. There were insufficient outcomes in individual CT-<em>APOE</em> cohorts to do the two-stage meta-analysis. In the one-stage meta-analysis of the CT-<em>APOE</em> criteria (1006 patients, median age 71 years [IQR 58–79, 477 [47%] female and 529 [53%] male), 74 patients had a recurrent intracerebral haemorrhage over 1495 person-years’ follow-up. Cumulative 3-year incidence of recurrent intracerebral haemorrhage was 34 (15%) of 320 patients in the high-risk CT-<em>APOE</em> cerebral amyloid angiopathy criteria group versus 14 (8%) of 322 patients in the low-risk group (adjusted sub-distribution HR 2·22 [95% CI 1·36–3·61], p=0·0014).<h3>Interpretation</h3>The Edinburgh CT-only and CT-<em>APOE</em> diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage were associated with a greater incidence of recurrent intracerebral haemorrhage. These findings could aid personalised prediction and targeted secondary prevention in standard clinical practice where brain CT is available.<h3>Funding</h3>UK Medical Research Council, The Stroke Association, The Wellcome Trust, and The British Heart Foundation.","PeriodicalId":22676,"journal":{"name":"The Lancet Neurology","volume":"75 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s1474-4422(25)00285-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Patients with lobar intracerebral haemorrhage and MRI biomarkers of cerebral amyloid angiopathy have a greater risk of recurrent intracerebral haemorrhage than patients without these biomarkers. However, access to MRI is limited. We aimed to determine whether the Edinburgh CT-only and CT-APOE diagnostic criteria for cerebral amyloid angiopathy-related lobar intracerebral haemorrhage are associated with recurrent intracerebral haemorrhage.

Methods

We did a meta-analysis of individual patient data from cohort studies identified at the 2018 International cerebral amyloid angiopathy conference in Lille, France, assessing patients with lobar intracerebral haemorrhage with available diagnostic CT imaging that had been, or could be, rated for the Edinburgh cerebral amyloid angiopathy criteria imaging features, and with follow-up data for recurrent intracerebral haemorrhage and death. Eligible patients were aged 16 years or older with first or recurrent spontaneous lobar intracerebral haemorrhage diagnosed by non-contrast brain CT, with no evidence of an underlying cause other than cerebral small vessel disease. Collaborators provided individual patient-level data. The primary outcome was first recurrent intracerebral haemorrhage occurring at least 30 days after the index event, analysed using primary two-stage (cohort-level) and secondary one-stage (pooled) meta-analyses with multivariable regression models with a competing risk of death, adjusted for age, sex, and CT small vessel disease score. Pooled analyses were adjusted for previous intracerebral haemorrhage, dementia, hypertension, and cohort clustering. All analyses were done in R Project for Statistical Computing (version 4.5.0).

Findings

We included eight cohorts from Austria, France, Germany, Italy, the UK, and the USA, with 1705 eligible patients for the CT-only criteria. In the primary two-stage meta-analysis of the CT-only criteria (562 patients from three European cohorts, median age 76 years [IQR 68–82], 282 [50%] female and 280 [50%] male), 69 patients had a recurrent intracerebral haemorrhage over 1381 person-years’ follow-up. The proportion with recurrent intracerebral haemorrhage during 5-year follow-up in the intermediate-risk and high-risk CT-only cerebral amyloid angiopathy criteria group was 48 (16%) of 307 patients compared with 21 (8%) of 255 patients in the low-risk group (adjusted sub-distribution hazard ratio [HR] 1·79, 95% CI 1·05–3·05, p=0·032). In the one-stage meta-analysis of the CT-only criteria (1620 patients with lobar intracerebral haemorrhage from eight cohorts, median age 73 years [IQR 62–80], 763 [47%] female and 857 [53%] male), 171 patients had a recurrent intracerebral haemorrhage over 3208 person-years’ follow-up. Cumulative 5-year incidence of recurrent intracerebral haemorrhage in the low-risk CT-only cerebral amyloid angiopathy criteria group was 45 (12%) of 727 patients compared with 54 (16%) of 513 patients in the intermediate-risk group (adjusted sub-distribution HR 1·68, 95% CI 1·21–2·32; p=0·0018), and 72 (26%) of 380 patients in the high-risk group (adjusted sub-distribution HR 2·97, 1·50–5·89, p=0·0018). We included six cohorts with 1021 eligible patients for the CT-APOE criteria; 15 patients with missing baseline data were excluded. There were insufficient outcomes in individual CT-APOE cohorts to do the two-stage meta-analysis. In the one-stage meta-analysis of the CT-APOE criteria (1006 patients, median age 71 years [IQR 58–79, 477 [47%] female and 529 [53%] male), 74 patients had a recurrent intracerebral haemorrhage over 1495 person-years’ follow-up. Cumulative 3-year incidence of recurrent intracerebral haemorrhage was 34 (15%) of 320 patients in the high-risk CT-APOE cerebral amyloid angiopathy criteria group versus 14 (8%) of 322 patients in the low-risk group (adjusted sub-distribution HR 2·22 [95% CI 1·36–3·61], p=0·0014).

Interpretation

The Edinburgh CT-only and CT-APOE diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage were associated with a greater incidence of recurrent intracerebral haemorrhage. These findings could aid personalised prediction and targeted secondary prevention in standard clinical practice where brain CT is available.

Funding

UK Medical Research Council, The Stroke Association, The Wellcome Trust, and The British Heart Foundation.
脑淀粉样血管病相关大叶性脑出血和复发性脑出血的爱丁堡CT与遗传诊断标准之间的关联:个体患者数据荟萃分析
背景:与没有这些生物标志物的患者相比,有脑叶性脑出血和脑淀粉样血管病MRI生物标志物的患者复发性脑出血的风险更高。然而,磁共振成像是有限的。我们的目的是确定爱丁堡CT-only和CT-APOE诊断标准对脑淀粉样血管病相关的大叶性脑出血是否与复发性脑出血相关。方法:我们对2018年在法国里尔举行的国际脑淀粉样蛋白血管病会议上确定的队列研究中的个体患者数据进行了荟萃分析,评估了已经或可能被评为爱丁堡脑淀粉样蛋白血管病标准影像学特征的脑叶性脑出血患者,以及复发性脑出血和死亡的随访数据。符合条件的患者年龄为16岁或以上,经非对比脑CT诊断为首次或复发性自发性大叶性脑出血,除脑小血管疾病外没有其他潜在原因的证据。合作者提供了个体患者层面的数据。主要结局是在指标事件发生后至少30天发生的首次复发性脑出血,使用具有竞争死亡风险的多变量回归模型(调整年龄、性别和CT小血管疾病评分)的初级两期(队列水平)和次级一期(汇总)荟萃分析进行分析。合并分析对既往脑出血、痴呆、高血压和队列聚类进行调整。所有分析均在R Project for Statistical Computing(4.5.0版本)中完成。研究结果:我们纳入了来自奥地利、法国、德国、意大利、英国和美国的8个队列,1705例符合ct标准的患者。在仅ct标准的主要两阶段荟萃分析中(来自三个欧洲队列的562例患者,中位年龄76岁[IQR 68-82], 282例[50%]女性,280例[50%]男性),69例患者在1381人年的随访中出现复发性脑出血。中危、高危ct脑淀粉样血管病标准组5年随访期间复发脑出血的比例为307例患者中48例(16%),而低危组255例患者中21例(8%)(校正亚分布风险比[HR] 1.79, 95% CI 1.05 ~ 3.05, p= 0.032)。在一项仅ct标准的单阶段荟萃分析中(来自8个队列的1620例脑叶性脑出血患者,中位年龄73岁[IQR 62-80], 763例(47%)女性,857例(53%)男性),171例患者在3208人年的随访中出现复发性脑出血。低危ct脑淀粉样血管病标准组5年累计脑出血复发发生率为727例患者中45例(12%),中危组513例患者中54例(16%)(校正亚分布HR 1.68, 95% CI 1.21 - 2.32, p= 0.0018),高危组380例患者中72例(26%)(校正亚分布HR 2.97, 1.50 - 5.89, p= 0.0018)。我们纳入了6个队列,1021例符合CT-APOE标准的患者;排除了基线资料缺失的15例患者。单个CT-APOE队列的结果不足以进行两阶段荟萃分析。在CT-APOE标准的单阶段荟萃分析中(1006例患者,中位年龄71岁[IQR 58-79],女性477例[47%],男性529例[53%]),在1495人年的随访中,74例患者出现复发性脑出血。高危CT-APOE脑淀粉样血管病标准组320例患者中累计3年复发脑出血发生率为34例(15%),而低危组322例患者中累计3年复发脑出血发生率为14例(8%)(调整后亚分布HR 2.22 [95% CI 1.36 - 3.61], p= 0.0014)。脑淀粉样血管病相关大叶性脑出血的爱丁堡CT-only和CT-APOE诊断标准与复发性脑出血的发生率较高相关。这些发现有助于在标准临床实践中进行个性化预测和有针对性的二级预防。资助:英国医学研究委员会、中风协会、威康信托基金会和英国心脏基金会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信